Registration Decision RD2020-16, Broflanilide, Cimegra, Teraxxa and Teraxxa F4
This decision is consistent with the Proposed Registration Decision, PRD2020-06, Broflanilide, Cimegra, Teraxxa and Teraxxa F4, which contains a detailed evaluation of the information submitted in support of this registration.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-03-29
Data overview
- Formats
- HTML
- File languages
- English, French